ArticleThe American journal of cardiology2017

Ninety-Day Readmission and Long-Term Mortality in Medicare Patients (≥65 Years) Treated With Ticagrelor Versus Prasugrel After Percutaneous Coronary Intervention (from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium).

Chris Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.